Cargando…

Aspartate transaminase to platelet ratio index (APRI) to assess liver fibrosis in patients with chronic liver disease

Detalles Bibliográficos
Autores principales:	Anania, Caterina, Pacifico, Lucia, Ferraro, Flavia, Olivero, Eugenia, Chiesa, Claudio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2011
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212797/ https://www.ncbi.nlm.nih.gov/pubmed/22087183

Ejemplares similares

Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)
por: Adler, Michael
Publicado: (2011)

Noninvasive assessment of liver fibrosis with the aspartate transaminase to platelet ratio index (APRI): Usefulness in patients with chronic liver disease: APRI in chronic liver disease
por: Yilmaz, Yusuf, et al.
Publicado: (2011)

Commentary on: Aspartate transaminase to platelet ratio index (APRI): A simple noninvasive index assessing liver fibrosis in patients with chronic liver diseases
por: Mao, Yilei, et al.
Publicado: (2011)

Commentary on: Noninvasive assessment of liver fibrosis using aspartate transaminase to platelet ratio index (APRI) in adult patients with chronic liver disease
por: El-Shabrawi, Mortada, et al.
Publicado: (2011)

Indirect markers of fibrosis in chronic liver diseases: Is aspartate transaminase-to-platelet ratio (APRI) a useful test?
por: Corte, Claudia Della, et al.
Publicado: (2011)

The Role of Aspartate Transaminase to Platelet Ratio Index (APRI) for the Prediction of Non-Alcoholic Fatty Liver Disease (NAFLD) in Severely Obese Children and Adolescents
por: Rigamonti, Antonello E., et al.
Publicado: (2022)

Is the aspartate transaminase to platelet ratio index adequate for the assessment of liver fibrosis in patients with chronic liver disease?
por: Parsian, Hadi
Publicado: (2011)

Correction: Rigamonti et al. The Role of Aspartate Transaminase to Platelet Ratio Index (APRI) for the Prediction of Non-Alcoholic Fatty Liver Disease (NAFLD) in Severely Obese Children and Adolescents. Metabolites 2022, 12, 155
por: Rigamonti, Antonello E., et al.
Publicado: (2022)

Aspartate transaminase to platelet ratio index (APRI) but not FIB-5 or FIB-4 is accurate in ruling out significant fibrosis in patients with non-alcoholic fatty liver disease (NAFLD) in an urban slum-dwelling population
por: Kolhe, Kailash Marotrao, et al.
Publicado: (2019)

Preoperative aspartate aminotransferase-to-platelet ratio index (APRI) is a predictor on postoperative outcomes of hepatocellular carcinoma
por: Cheng, JiWen, et al.
Publicado: (2016)

Mediterranean diet and nonalcoholic fatty liver disease
por: Anania, Caterina, et al.
Publicado: (2018)

Role of the Aspartate Transaminase and Platelet Ratio Index in Assessing Hepatic Fibrosis and Liver Inflammation in Adolescent Patients with HBeAg-Positive Chronic Hepatitis B
por: Zhijian, Yu, et al.
Publicado: (2015)

Accuracy of gamma-glutamyl transpeptidase-to-platelet ratio (GPR), red cell distribution width (RDW), aspartate aminotransferase-to-platelet ratio index (APRI), and the fibrosis-4 index (FIB4) compared with liver biopsy in patients with drug-induced liver injury (DILI)
por: Wan, Minjie, et al.
Publicado: (2021)

Aspartate aminotransferase to platelet ratio index for the assessment of liver fibrosis severity in patients with chronic hepatitis
por: Sirli, Roxana, et al.
Publicado: (2011)

The Roles of Fibrosis Index Based on Four Factors and Aspartate Transaminase-to-Platelet Ratio Index Scoring Systems as an Alternative to Transient Elastography Liver Stiffness in Liver Fibrosis Staging in Human Immunodeficiency Virus and Hepatitis C Virus Co-Infected Patients
por: Ajao, Susanne, et al.
Publicado: (2021)

Aspartate aminotransferase-to-platelet ratio index (APRI): A potential marker for diagnosis in patients at risk of severe malaria caused by Plasmodium vivax
por: Guedes, Karla Sena, et al.
Publicado: (2019)

Gamma-glutamyl-transpeptidase to platelet ratio is not superior to APRI,FIB-4 and RPR for diagnosing liver fibrosis in CHB patients in China
por: Huang, Rui, et al.
Publicado: (2017)

The liver fibrosis index is superior to the APRI and FIB-4 for predicting liver fibrosis in chronic hepatitis B patients in China
por: Huang, Dedong, et al.
Publicado: (2019)

Aspartate Aminotransferase to Platelet Ratio Index and Fibrosis-4 Index for Detecting Liver Fibrosis in Patients With Autoimmune Hepatitis: A Meta-Analysis
por: Dong, Bingtian, et al.
Publicado: (2022)

Aspartate aminotransferase-platelet ratio index, adiponectin and body mass index in children with fatty liver
por: Kusumawati, Ninung RD, et al.
Publicado: (2013)

Is aspartate aminotransferase-to-platelet ratio index a biomarker in the evaluation of advanced fibrosis in non-alcoholic fatty liver disease?
por: Agilli, Mehmet, et al.
Publicado: (2014)

What is the performance of the Aspartate Aminotransferase to platelets Ratio Index in patients With Chronic Liver Disease?
por: Zarski, Jean Pierre
Publicado: (2011)

Clinicopathological correlation of aspartate aminotransferase-to-platelet ratio (APRI) and aspartate aminotransferase-to-alanine aminotransferase ratio (AAR) with survival in esophageal carcinoma patients: a retrospective cohort analysis of 951 patients
por: Zafar, Muhammad Talha, et al.
Publicado: (2023)

Immune response to vaccines in children with celiac disease
por: Anania, Caterina, et al.
Publicado: (2017)

A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI)
por: Ji, Fei, et al.
Publicado: (2016)

Use of aspartate aminotransferase to platelet ratio to reduce the need for FibroScan in the evaluation of liver fibrosis
por: Wong, Stephanie, et al.
Publicado: (2017)

Comparison of patients using lamivudine, entecavir, and tenofovir according to liver fibrosis markers fibrosis-4 and aspartate aminotransferase-to-platelet ratio index scores
por: Okan, Huseyin Dogus, et al.
Publicado: (2023)

Fibroscan Compared to FIB-4, APRI, and AST/ALT Ratio for Assessment of Liver Fibrosis in Saudi Patients With Nonalcoholic Fatty Liver Disease
por: Fallatah, Hind I., et al.
Publicado: (2016)

AST to Platelet Ratio Index (APRI) is an easy-to-use predictor score for cardiovascular risk in metabolic subjects
por: De Matteis, Carlo, et al.
Publicado: (2021)

Cardiometabolic risk factors in children with celiac disease on a gluten-free diet
por: Anania, Caterina, et al.
Publicado: (2017)

APRI Score as a Predictor of Significant Liver Fibrosis in Chronic Hepatitis B
por: Ayed, Houda Ben, et al.
Publicado: (2017)

Association of Nonalcoholic Fatty Liver Disease with Subclinical Cardiovascular Changes: A Systematic Review and Meta-Analysis
por: Bonci, Enea, et al.
Publicado: (2015)

A novel online calculator based on albumin-bilirubin and aspartate transaminase-to-platelet ratio index for predicting postoperative morbidity following hepatectomy for hepatocellular carcinoma
por: Sun, Li-Yang, et al.
Publicado: (2020)

The association of aspartate transaminase-to-alanine transaminase ratio and metabolic syndrome among HIV patients in Sidama Region, South Ethiopia
por: Abera, Wondwossen, et al.
Publicado: (2023)

Prognostic Role of Pretreatment De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase Ratio) in Urological Cancers: A Systematic Review and Meta-Analysis
por: Su, Shiqiang, et al.
Publicado: (2020)

The Association between Fruit and Vegetable Intake and Liver Enzymes (Aspartate and Alanine Transaminases) in Tehran, Iran
por: Mollahosseini, Mehdi, et al.
Publicado: (2017)

Preoperative aspartate aminotransferase-to-platelet-ratio index as a predictor of posthepatectomy liver failure for resectable hepatocellular carcinoma
por: Mai, Rong-Yun, et al.
Publicado: (2019)

Prognostic Value of Aspartate Transaminase/Alanine Transaminase Ratio in Patients With Hepatitis B Virus-Related Hepatocellular Carcinoma Undergoing Hepatectomy
por: Mo, Qiuyan, et al.
Publicado: (2022)

The aspartate aminotransferase-to-platelet ratio and the evaluation of non-alcoholic fatty liver disease
por: Tapper, Elliot B.
Publicado: (2014)

Prognostic value of aspartate transaminase to alanine transaminase (De Ritis) ratio in solid tumors: a pooled analysis of 9,400 patients
por: Wu, Jiayuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_32mguqpardq4vg2l34mnihd4r6